Effects of Ginkgo biloba extract and preconditioning on the diabetic rat myocardium

Diabetologia

Volumn 39, Issue 11, 1996, Pages 1255-1262

  Tosaki, A ^a   Pali, T ^b   Droy Lefaix, M T ^c  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

^b INSTITUTE OF BIOCHEMISTRY   (Hungary)

^c IPSEN   (France)

Author keywords

Arrhythmias; Diabetes mellitus; Free radicals; Ginkgo biloba extract; Preconditioning

Indexed keywords

GINKGO BILOBA EXTRACT; OXYGEN RADICAL; STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART MUSCLE ISCHEMIA; INSULIN DEPENDENT DIABETES MELLITUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ARRHYTHMIA; COHORT STUDIES; DIABETES MELLITUS, EXPERIMENTAL; ELECTRON SPIN RESONANCE SPECTROSCOPY; FREE RADICAL SCAVENGERS; GINKGO BILOBA; INCIDENCE; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION; PLANT EXTRACTS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TACHYCARDIA; VENTRICULAR FIBRILLATION;

EID: 0029856384     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050567     Document Type: Article

References (42)

1. Ferdinandy P, Szilvassy Z, Csont T et al. (1995) Nitroglycerin-induced direct protection of the ischaemic myocardium in isolated working hearts of rats with vascular tolerance to nitroglycerin. Br J Pharmacol 115: 1129-1131
2. Szilvassy Z, Ferdinandy P, Bor P, Jakab I, Lonovics J, Koltai M (1994) Ventricular overdrive pacing-induced anti-ischaemic effect: a conscious rabbit model of preconditioning. Am J Physiol 266:H2033-H2041
3. Reimer KA, Hill ML, Jennings RB (1981) Prolonged depletion of ATP and the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischaemic injury in dogs. J Mol Cell Cardiol 13: 229-239
4. Deutsch E, Berger M, Kussmaul WG, Hirshfeld JW, Herrmann HC, Laskey WK (1990) Adaptation to ischaemia during percutaneous transluminal coronary angioplasty: clinical, hemodynamic, and metabolic features. Circulation 82: 2044-2051
5. Yellon DM, Alkhulaifi AM, Pugsley WB (1993) Preconditioning the human myocardium. Lancet 342: 276-277
6. Reimer KA, Murry CE, Yamasawa I, Hill ML., Jennings RB (1986) Four brief periods of myocardial ischaemia cause no cumulative ATP loss or necrosis. Am J Physiol 251:H1306-H1315
7. Murry CE, Jennings RB, Reimer KA (1986) Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124-1136
8. Murry CE, Richard VJ, Reimer KA, Jennings RB (1990) Ischaemic preconditioning slows energy metabolism and delays ultrastructural damage during a sustained ischaemic episode. Circ Res 66: 913-931
9. 1 receptors in rabbit heart. Am J Physiol 84:H350-H356
10. Vegh A, Szekeres L, Parratt JR (1990) Protective effects of preconditioning of the ischaemic myocardium involve cyclooxygenase products. Cardiovasc Res 24: 1020-1023
11. 2 receptor through a protein kinase C signaling pathway. Circ Res 78: 73-81
12. Goldhaber JI, Lamp ST, Weiss JN (1989) Effects of exogenous free radicals on electromechanical function and metabolism in isolated rabbit and guinea pig ventricle. J Clin Invest 83: 1800-1809
13. Liu Y, Thornton JD, Cohen MV, Downey JM, Schaffer SW (1993) Streptozotocin-induced non-insulin-dependent diabetes protects the heart from infarction. Circulation 88: 1273-1278
14. Asimakis GK, Inners-McBride K, Conti VR (1993) Attenuation of postischaemic dysfunction by ischaemic preconditioning is not mediated by adenosine in the isolated rat heart. Cardiovasc Res 27: 1522-1530
15. Lasley RD, Anderson GM, Mentzer RM (1993) Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 27: 565-570
16. Sandhu R, Diaz RJ, Wilson GJ (1993) Comparison of ischaemic preconditioning in blood perfused and buffer perfused isolated heart models. Cardiovasc Res 27: 602-607
17. Tosaki A, Cordis GA, Szerdahelyi P, Engelman RM, Das DK (1994) Effects of preconditioning on re-perfusion arrhythmias, myocardial functions, formation of free radicals, and ion shifts in isolated ischaemic/re-perfused rat hearts. J Cardiovasc Pharmacol 23: 365-373
18. Yang BC, Nicolini FA, Nichols WW, Mehta JL (1994) Failure of brief ischaemic episodes to protect against myocardial dysfunction caused by ischaemia and re-perfusion in isolated rat hearts. Am Heart J 128: 1192-1200
19. Tosaki A, Hellegouarch A (1994) Adenosine triphosphate-sensitive potassium channel blocking agent ameliorates, but the opening agent aggravates, ischaemia/re-perfusion-induced injury: heart function studies in nonfibrillating isolated hearts. J Am Coll Cardiol 23: 487-496
20. Blasig IE, Ebert B, Hennig C, Pali T, Tosaki A (1990) Inverse relationship between ESR spin trapping of oxyradicals and degree of functional recovery during myocardial re-perfusion in isolated working rat heart. Cardiovasc Res 24: 263-270
21. Vadlamudi RVSV, McNeill JH (1983) Effect of alloxan and streptozotocin-induced diabetes on isolated rat heart responsiveness to carbachol. J Pharmacol Exp Ther 225: 410-415
22. Tosaki A, Blasig IE, Pali T, Ebert B (1990) Heart protection and radical trapping by DMPO during re-perfusion in isolated working rat hearts. Free Rad Biol Med 8: 363-372
23. Tosaki A, Braquet P (1990) DMPO and re-perfusion injury: arrhythmia, heart function, electron spin resonance, and nuclear magnetic resonance studies in isolated working guinea pig hearts. Am Heart J 120: 819-830
24. Ambrosio G, Zweier JL, Jacohus WE, Weisfeldt ML, Flaherty JT (1987) Improvement of postischaemic myocardial function and metabolism induced by administration of desferrioxamine at the time of re flow: the role of iron in the pathogenesis of re-perfusion injury. Circulation 76: 906-915
25. Hearse DJ, Tosaki A (1987) Re-perfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol 9: 641-650
26. Szabo ME, Droy-Lefaix MT, Doly M, Carre C, Braquet P (1991) Ischaemia and re-perfusion-induced histologic changes in rat retina: demonstration of a free radical-mediated mechanism. Invest Ophthalmol Vis Sci 32: 1471-1478
27. Drieu K (1986) Preparation et definition de l'extrait de Ginkgo biloba. La Presse Medicale 31: 1455-1457
28. Cribier A, Korsatz L, Koning R et al. (1992) Improved myocardial ischaemic response and enhanced collateral circulation with long repetitive coronary occlusion during angioplasty: a prospective study. J Am Coll Cardiol 20: 578-586
29. Kloner RA, Shook T, Przyklenk K et al. (1995) Previous angina alters in hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 91: 37-47
30. Marcocci L, Packer L, Droy-Lefaix MT, Sekaki A, Gardes-Albert M (1994) Antioxidant action of Ginkgo biloba extract EGb 761. Methods Enzymol 234: 462-475
31. Lasker JM, Huang MT, Conney AH (1982) In vivo activation of zoxazolamine metabolism by flavone. Science 216: 1419-1421
32. 2 free radicals: an alpha-radiolysis study. Free Rad Biol Med 9: 190 (Abstract)
33. Slater TF, Cheeseman KH, Davies MJ (1987) Free radical scavenging properties of modulators of eicosanoid metabolism. Adv Prostaglandin Thromboxane Leuko Res 17: 1098-1102
34. Gabor M (1979) Anti-inflammatory substances of plant origin. In: Vane JR, Ferreira SH (eds) Handbook of experimental pharmacology. Vol. 50, part 2: Anti-inflammatory drugs. Springer, Berlin pp 698-739
35. Johnson EF, Schwab GE, Vickery LE (1988) Positive effectors of the binding of an active site-directed amino steroid to rabbit cytochrome P-450 3c. J Biol Chem 263: 17672-17677
36. Hearse DJ, Tosaki A (1988) Free radicals and calcium: simultaneous interacting triggers as determinants of vulnerability to re-perfusion-induced arrhythmias in the rat heart. J Mol Cell Cardiol 20: 213-223
37. Tosaki A, Engelman DT, Pali T, Engelman RM, Droy-Lefaix MT (1994) Ginkgo biloba extract (EGb 761) improves postischaemic function in isolated preconditioned working rat hearts. Cor Artery Dis 5: 443-450
38. 1B-adrenoceptors, pertussis toxin-sensitive G proteins, and protein kinase C. Circulation 92: 2259-2265
39. Garber DW, Everett AW, Neely JR (1983) Cardiac function and myosin ATPase in diabetic rats treated with insulin, T3, and T4. Am J Physiol 244:H592-H598
40. 2+ pump activity during diabetes mellitus. Am J Physiol 252:H540-H544
41. Xiang H, McNeill JH (1991) Alpha 1-adrenoceptor-mediated phosphoinositide breakdown and inotropic responses in diabetic hearts. Am J Physiol 260:H557-H562
42. Rodrigues B, McNeill JH (1992) The diabetic heart: metabolic cause for the development of a cardiomyopathy. Cardiovasc Res 26: 913-922